Response to: Prescribed Minimum Benefits complaints: A 5-year retrospective review
DOI:
https://doi.org/10.7196/SAMJ.2024.v114i10.2450Keywords:
dyslipidaemia, Prescribed Minimum BenefitsAbstract
-
References
1. Ngobeni LM, Moropeng ML, Thsehla E. Prescribed Minimum Benefits complaints: A 5-year retrospective review. S Afr Med J 2024;114(6b):e1007. https://doi.org/10.7196/SAMJ.2024. v114i6b.1007
2. Klug QE, E Klug, F J Raal, et al. South African dyslipidaemia guideline consensus statement: 2018 update. A joint statement from the South African Heart Association (SA Heart) and the Lipid and Atherosclerosis Society of Southern Africa (LASSA). S Afr Med J 2018;108(11b):973-1000. S Afr Med J 2018;108(Part 2):973-1000. https://doi.org/10.7196/SAMJ.2018.v108i11.13383
3. Klug QE, Raal FJ. Heart groups in South Africa advocate for tighter LDL-C control and lipoprotein(a) testing to curb atherosclerotic cardiovascular disease. S Afr Med J 2024;114(5):e1973. https://doi. org/10.7196/SAMJ.2024.v114i5.1973
4. Marais AD, Blom DJ, Raal FJ. Familial hypercholesterolaemia in South Africa: A reminder. S Afr Med J 2021;111(8):700-701. http://doi.org/10.7196%2FSAMJ.2021.v111i8.15782
5. Marais AD, Blom DJ. Discovering hypertriglyceridaemia. S Afr Med J 2021;111(8):697. https://doi. org/10.7196/SAMJ.2021.v111i8.15783
6. Marais AD, Blom DJ, Raal FJ. Management of hyperlipidaemia. S Afr Med J 2024;114(4):e1016. https:// doi.org/10.7196/SAMJ.2024.v114i4.1016
Downloads
Published
Issue
Section
License
Copyright (c) 2024 A D Marais, D J Blom, F J Raal
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Licensing Information
The SAMJ is published under an Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited.
Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository.
Publishing Rights
Authors grant the Publisher the exclusive right to publish, display, reproduce and/or distribute the Work in print and electronic format and in any medium known or hereafter developed, including for commercial use. The Author also agrees that the Publisher may retain in print or electronic format more than one copy of the Work for the purpose of preservation, security and back-up.
